Louis Champel
Director/Board Member bei VETOQUINOL SA
Profil
Louis Champel is an Independent Director at Vétoquinol SA since 2009.
Prior to this, he was the Chief Executive Officer at Rhone Merieux.
He also served as the Chairman & Chief Executive Officer at Merial SAS from 1997 to 2000.
From 2002 to 2008, he was the Managing Director at Lyon 3 Valorisation.
Mr. Champel completed his undergraduate degree at Sciences Po.
Aktive Positionen von Louis Champel
| Unternehmen | Position | Beginn |
|---|---|---|
| VETOQUINOL SA | Director/Board Member | 22.09.2010 |
Ehemalige bekannte Positionen von Louis Champel
| Unternehmen | Position | Ende |
|---|---|---|
| Lyon 3 Valorisation | Chief Executive Officer | 01.01.2008 |
Merial SAS
 Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Chief Executive Officer | 01.01.2000 |
Rhone Merieux
 Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Chief Executive Officer | - |
Ausbildung von Louis Champel
| Sciences Po | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VETOQUINOL SA | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
| Lyon 3 Valorisation |
